The decision to close a PFO after a stroke should certainly only be made after extensive testing and collaboration by patients and clinicians working closely together. From my experience being involved as a stroke patient advocate and following the stories of cryptogenic stroke patients with PFO over time, I’ve learned first hand that part of the obstacle presented in this collaboration is that cardiologists and neurologists often couldn’t do the same to reach consensus. The data is now showing that pfo closure is effective compared to medical therapy. Will these new studies make the decision process any easier for the patient now that cardiologists and neurologists might have found common ground ?
I’m not able to answer that question, but I did find this quote very interesting, because after all this time I can attest as patients, this is all we ever wanted!
“The most important lesson from the recently published PFO trials is that cardiologists and neurologists working together is the key to identifying patients most likely to benefit from PFO closure,” wrote Andrew Farb.
Source: American Academy of Neurology’s Neurology Today Online–
Read the full article:
In the Clinic-Patent Foramen Ovale Closure and Stroke: PFO Closure Associated with Fewer Recurrent Ischemic Strokes Compared to Medical Therapy